Beone Medicines Ltd share price logo

Beone Medicines Ltd Share Price

NASDAQ: ONC

Large Cap

$314.51

-2.48

(-0.78%)

as on

Beone Medicines Ltd Stock Performance

as on March 3, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $304.77
    $315.00
    downward going graph

    3.10%

    Downside

    0.16%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $196.45
    $385.22
    downward going graph

    37.54%

    Downside

    22.48%

    Upside

    downward going graph

Beone Medicines Ltd share price movements today

Previous Close
$316.99
Open
$305.50
Volume
279.0K
Day's Low - High
$304.77 - $315.00
52 Week Low - High
$196.45 - $385.22

Beone Medicines Ltd Historical Returns

1 Month Return
-9.24 %
3 Month Return
-6.96 %
1 Year Return
+ 28.03 %
3 Year Return
0 %
5 Year Return
0 %

Beone Medicines Ltd Stock Fundamentals & Key Indicators

Check Beone Medicines Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$35.1B

EPS (TTM)

5.5861

Dividend Yield

0.00%

PE Ratio (TTM)

621.55

Industry PE ratio

0

PEG Ratio

0

Return On Equity TTM

7.46%

Beone Medicines Ltd Stock Valuation

Track how Beone Medicines Ltd P/E has moved over time to understand its valuation trends.

Beone Medicines Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-87.89x)

March 31, 2025

Industry (0.00x)

March 3, 2026

Today (621.55x)

March 3, 2026

Highest (141.90x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 621.55x

Beone Medicines Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Beone Medicines Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$35.1BNA621.555.37%
BUY$126.2B133.18%32.4732.94%
BUY$44.2B125.24%142.888.45%
BUY$82.6B77.02%18.8331.41%

Stock Returns calculator for Beone Medicines Ltd Stock including INR - Dollar returns

The Beone Medicines Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Beone Medicines Ltd investment value today

Current value as on today

₹1,32,912

Returns

₹32,912

(+32.91%)

Returns from Beone Medicines Ltd Stock

₹28,094 (+28.09%)

Dollar Returns*

₹4,817 (+4.82%)

Beone Medicines Ltd Stock’s Investor Sentiment and Interest

Search interest for Beone Medicines Ltd Stock has increased by 19% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:19% versus previous 30 day period

Beone Medicines Ltd Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
781
634
751
929
1,001
1,127
1,117
1,315
1,412
1,498
Gross Profit
684
528
626
791
831
967
952
1,150
1,215
1,355
Operating Income
-133
-383
-261
-107
-120
-79
11
87
163
185
EBITDA
-112
-359
-236
-83
-48
-29
43
123
163
417
Interest Expense
-
-
-
-
-
-
-
-
-
58
Depreciation
21
23
25
24
71
50
32
35
37
-
Income Before Tax
229
-350
-243
-105
-98
-85
20
99
147
149
Income Tax Expense
13
16
7
14
23
66
19
5
22
82
Net Income
215
-367
-251
-120
-121
-151
1
94
124
66
Net Profit Margin
27.57%
-57.94%
-33.41%
-12.96%
-12.12%
-13.47%
0.11%
7.17%
8.84%
4.44%

Beone Medicines Ltd Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
238
198
428
308
1,176
1,415
2,458
3,810
5,343
Gross Profit
-96
-35
-509
357
238
1,011
1,129
2,078
3,216
4,674
Operating Income
-117
-98
-705
-959
-1,657
-1,438
-1,789
-1,207
-568
447
EBITDA
-115
-93
-695
-941
-1,625
-1,392
-1,723
-1,120
-396
616
Interest Expense
0
4
13
-
-
-
52
-
-
58
Depreciation
-
-
-
-
31
46
66
87
171
-
Income Before Tax
-119
-91
-689
-943
-1,618
-1,438
-1,961
-825
-533
416
Income Tax Expense
0
2
-15
6
10
19
42
55
111
129
Net Income
-119
-93
-673
-948
-1,624
-1,457
-2,003
-881
-644
286
Net Profit Margin
-11141.78%
-39.06%
-339.91%
-221.53%
-526.10%
-123.93%
-141.52%
-35.86%
-16.92%
5.37%

Beone Medicines Ltd Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-367
-251
-120
-121
-151
1
94
124
382
Operating Cash Flow
-221
-308
-95
188
75
44
263
402
417
Investing Cash Flow
-62
-209
-111
-133
-93
-121
-66
-49
-38
Financing Cash Flow
347
162
23
12
-4
-33
35
961
96
Change in Cash
105
-378
-189
95
-74
-108
255
1,324
499

Beone Medicines Ltd Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-93
-674
-950
-1,600
-1,413
-2,003
-881
-644
286
Operating Cash Flow
12
-547
-750
-1,283
-1,298
-1,496
-1,157
-140
1,127
Investing Cash Flow
-356
-637
554
-3,168
640
1,077
60
-548
-276
Financing Cash Flow
490
1,690
85
5,202
3,636
-18
416
193
1,059
Change in Cash
152
501
-119
769
2,992
-507
-689
-547
1,970

Insights on Beone Medicines Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Beone Medicines Ltd has shown consistent growth in its revenue over the last four quarters. The revenue increased from $1.11 billion to $1.49 billion, representing an average growth of 9.2% each quarter.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 33.5% return, outperforming this stock by 5.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 60.5% return, outperforming this stock by 30.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Beone Medicines Ltd has experienced a decline in profit over the last two quarters. The net profit decreased from $124.84 million to $66.50 million, which represents an average decrease of 46.7% each quarter.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ONC stock has moved down by -14.8%

About Beone Medicines Ltd

BeOne Medicines AG, formerly BeiGene, Ltd., is a global oncology company engaged in discovering and developing treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, the Company is engaged in the development of its diverse pipeline of novel therapeutics. Its products include Brukinsa, Tevimbra and Pamiparib. Brukinsa is an orally available, small-molecule inhibitor of Bruton’s tyrosine kinase (BTK). Tevimbra is a humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is designed to minimize binding to Fc-gamma (Fcy) receptors on macrophages, helping the body’s immune cells detect and fight tumors. The Company’s product pipeline in development includes Sonrotoclax, Tarlatamab, Zanidatamab, Blinatumomab, BGB-26808, BGB-R046, BG-68501, BG-C9074, BGB-43395, Xaluritamig, and others.
OrganisationBeone Medicines Ltd
Headquarters94 Aeschengraben 27, Basel, Switzerland, 4051
CEOMr. John V. Oyler
E-voting on sharesClick here to vote

Key Management of Beone Medicines Ltd

Name

Title

Mr. Wang Lai Ph.D.

President and Global Head of Research & Development

Dr. Xiaodong Wang Ph.D.

Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder

Mr. Aaron Rosenberg

Chief Financial Officer

Mr. Marcello Damiani

Chief Technology Officer

Dr. Mark Lanasa

Senior VP & Chief Medical Officer for Solid Tumors

Mr. Graham Hardiman

Global Head of Human Resources

Mr. John V. Oyler

Co-Founder, Executive Chairman & CEO

Ms. Liza Heapes

Head of Investor Relations

Ms. Eleanor Duff Ph.D.

Senior VP & Head of Corporate Communications

Mr. Chan Lee

General Counsel & Senior VP

FAQs

What is Beone Medicines Ltd share price today?

Beone Medicines Ltd share price today is $314.51 as on at the close of the market. Beone Medicines Ltd share today touched a day high of $315 and a low of $304.77.

What is the 52 week high and 52 week low for Beone Medicines Ltd share?

Beone Medicines Ltd share touched a 52 week high of $385.22 on and a 52 week low of $196.45 on . Beone Medicines Ltd stock price today i.e. is closed at $314.51,which is 18.36% down from its 52 week high and 60.10% up from its 52 week low.

What is Beone Medicines Ltd's market capitalisation today?

Beone Medicines Ltd market capitalisation is $0.04T as on .

How to invest in Beone Medicines Ltd Stock (ONC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Beone Medicines Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Beone Medicines Ltd Shares that will get you 0.0048 shares as per Beone Medicines Ltd share price of $314.51 per share as on March 3, 2026 at 2:29 am IST.

What is the minimum amount required to buy Beone Medicines Ltd Stock (ONC) from India?

Indian investors can start investing in Beone Medicines Ltd (ONC) shares with as little as ₹91.474 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹914.74 in Beone Medicines Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Beone Medicines Ltd share’s latest price of $314.51 as on March 3, 2026 at 2:29 am IST, you will get 0.0318 shares of Beone Medicines Ltd. Learn more about fractional shares .